Enveric Biosciences Announces Two Poster Presentations at th

Presentations highlight research involving Enveric’s EVM301 Series of non-hallucinogenic neuroplastogens and the company’s lead product candidate, EB-373

...

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Australia , Boston , Massachusetts , United States , Enveric Biosciences , Jillianm Hagel , D Enveric Biosciences , Peter Facchini , Natali Ozber , Joseph Tucker , Charlie Cai , Josephe Tucker , Jessicab Lee , Lisa Yu , Kaveh Matinkhoo , Stanley Opare , Sheetala Raithatha , Sarahg Cook , Jaideep Bains , Peterj Facchini , Govinda Sharma , Jaideeps Bains , Neuropsychiatric Drug Development Summit , Exchange Commission , Chief Innovation Officer , Limei Chang , Glynnis Jensen , David Press , Jonathan Gallant , New Chemical Entities , Annual Report , Quarterly Reports , Markets ,